Company Savient Pharmaceuticals Inc Nasdaq
Equities
US80517Q1004
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 73,373,388 | 71,978,397 ( 98.10 %) | 0 | 98.10 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- SVNTQ Stock
- Stock
- Company Savient Pharmaceuticals Inc